Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)–Coalition IV trial()()

BACKGROUND: Observational studies have suggested a higher risk of thrombotic events in patients with coronavirus disease 2019 (COVID-19). Moreover, elevated D-dimer levels have been identified as an important prognostic marker in COVID-19 directly associated with disease severity and progression. Pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes, Renato D., de Barros e Silva, Pedro Gabriel Melo, Furtado, Remo H.M., Macedo, Ariane Vieira Scarlatelli, Ramacciotti, Eduardo, Damini, Lucas Petri, Bronhara, Bruna, Cavalcanti, Alexandre B., Rosa, Regis G., Azevedo, Luciano C.P., Veiga, Viviane C., Machado, Flávia R, Ritt, Luiz Eduardo, Martins, Priscilla de Aquino, Alexander, John H., Avezum, Alvaro, Berwanger, Otavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Trial Designs
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057688/
https://www.ncbi.nlm.nih.gov/pubmed/33891907
http://dx.doi.org/10.1016/j.ahj.2021.04.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057688/
https://www.ncbi.nlm.nih.gov/pubmed/33891907
http://dx.doi.org/10.1016/j.ahj.2021.04.005

Ejemplares similares